Singapore builds a local repository for validated patient-reported outcome measures
A new scoping review has assembled the most comprehensive map yet of patient-reported outcome measures validated for use in Singapore, cataloguing 115 instruments across 165 studies. For clinicians, health services researchers, and outcomes teams trying to choose the right questionnaire for the right patient, the practical value is immediate: the review separates tools with local psychometric support from those still being used without Singapore-specific validation.
The work is especially relevant as value-based care models continue to depend on outcomes that patients themselves can report. Pain, function, symptom burden, quality of life, and daily disability are often invisible to laboratory data and imaging alone. A repository built around local validation gives those measures a firmer clinical footing.
What the Singapore review actually assembled
The review searched PubMed, Embase, Scopus, PsycINFO, Factiva, and ProQuest for studies published up to 19 September 2024, following PRISMA-ScR guidance. From that evidence base, the investigators identified 115 locally validated PROMs and grouped the psychometric evidence using COSMIN domains: reliability, validity, responsiveness, and interpretability.
Two instruments stood out by volume of use: the EuroQol 5 Dimension questionnaire and the 36-Item Short Form Health Survey. Both have broad international recognition, but the review shows they also occupy a central place in Singapore-specific measurement work. Their repeated validation across studies suggests they remain the most familiar tools in the local outcomes ecosystem, especially when cross-condition comparison matters.
A total of 35 conditions were represented. Musculoskeletal disease accounted for the largest share of locally validated PROMs, reflecting a field in which pain, function, and health-related quality of life are all highly measurable from the patient’s perspective. Other clinical areas had a far thinner evidence base.
Reliability and validity dominated the psychometric work
The most frequently assessed properties were validity and reliability. In practical terms, that means most studies asked whether the instrument measured what it was supposed to measure and whether it did so consistently. Those are the first barriers any PROM must clear before it can move from a research setting into routine care.
The review also tracked responsiveness and interpretability, but these properties appeared less often than reliability and validity. That matters because a questionnaire can be internally consistent and still fail in clinic if it cannot detect change after treatment or if score differences remain hard to interpret at the bedside. In day-to-day practice, a PROM is only useful when a clinician can tell whether a score has moved enough to matter.
A repository organized around these psychometric domains gives users a faster way to choose between tools, especially when several instruments exist for the same condition. Rather than treating all questionnaires as interchangeable, the review makes the measurement history visible.
Gaps in pneumonia, cesarean section, and hemorrhoidectomy are hard to ignore
Some conditions widely encountered in clinical care had no validated PROMs identified in Singapore, including pneumonia, caesarean section, and hemorrhoidectomy. Those gaps are more than a cataloging issue. They leave clinicians and researchers with little local evidence on whether imported questionnaires perform well in Singaporean patients, where language, cultural context, expectations of care, and symptom reporting may differ from the populations in which a tool was first developed.
The absence of validated PROMs in these areas also exposes a mismatch between measurement effort and clinical burden. Acute infections, perioperative recovery, and common surgical procedures are precisely the settings where patient experience can change quickly and meaningfully. Without validated local instruments, these shifts may remain undercaptured.
The review places those omissions in sharp relief. Some of the most common conditions seen in hospitals and surgical wards still lack a Singapore-validated patient voice.
Why value-driven care depends on local validation
Singapore’s Value Driven Care conditions were explicitly considered in the review, adding another layer of practical relevance. If health systems want to compare outcomes across hospitals, specialties, or time periods, they need tools that are not only statistically sound but also appropriate for the local patient population. Imported instruments can be useful, but local validation reduces the risk of hidden measurement error when they are deployed in a different setting.
For chronic disease management, PROMs can capture fatigue, functional limitation, emotional burden, and symptom control in ways that complement biometric endpoints. For surgical and acute care pathways, they can track recovery, pain relief, and return to baseline function. The Singapore repository gives these uses a more coherent evidence base and can help prevent uncritical reuse of measures that have never been properly tested in local patients.
The study also offers a roadmap for researchers planning new validation work. Conditions with no Singapore-validated PROMs are now easier to spot, and future studies can target those gaps rather than duplicating work already done.
A practical resource for clinics, trials, and quality programs
The repository should help clinicians avoid one of the more common failures in outcomes research: choosing a questionnaire because it is popular rather than because it is locally supported. In settings where PROM data feed registry work, comparative effectiveness studies, or quality dashboards, instrument choice can shape the conclusions that follow.
For investigators, the review provides an evidence map that can guide study design, endpoint selection, and translation work. For health systems, it offers a more structured view of which patient-centered measures are ready for routine use and which still need psychometric attention. For patients, the benefit is simpler but no less important: their reported symptoms and quality-of-life changes are more likely to be measured with tools that have been tested in the same healthcare environment in which they are treated.
The repository is not static. It will need updating as new instruments are validated and as clinical priorities change. Even so, the current map is substantial: 115 PROMs, 165 studies, 35 conditions, and clear blind spots that future validation studies can no longer ignore.